Your browser doesn't support javascript.
loading
Low-dose radiotherapy for extranodal marginal zone B lymphoma of the lip: Case report and literature review.
Bianco, Lavinia; Solla, Salvatore Dario; Parvis, Guido; Gino, Eva; Bollito, Enrico; Filippi, Andrea Riccardo; Massa, Francesca; Ruo Redda, Maria Grazia.
Afiliação
  • Bianco L; Department of Radiation Oncology, University of Turin School of Medicine, Mauriziano Umberto I Hospital, Turin, Italy.
  • Solla SD; Department of Radiation Oncology, University of Turin School of Medicine, Mauriziano Umberto I Hospital, Turin, Italy.
  • Parvis G; Department of Hematology, University of Turin School of Medicine, Mauriziano Umberto I Hospital, Turin, Italy.
  • Gino E; Department of Medical Physics, Mauriziano Umberto I Hospital, Turin, Italy.
  • Bollito E; Department of Pathology, University of Turin School of Medicine, San Luigi Gonzaga Hospital, Turin, Italy.
  • Filippi AR; Department of Radiation Oncology, University of Turin School of Medicine, San Luigi Gonzaga Hospital, Turin, Italy.
  • Massa F; Department of Pathology, University of Turin School of Medicine, San Luigi Gonzaga Hospital, Turin, Italy.
  • Ruo Redda MG; Department of Radiation Oncology, University of Turin School of Medicine, Mauriziano Umberto I Hospital, Turin, Italy. Electronic address: mariagrazia.ruoredda@unito.it.
Hematol Oncol Stem Cell Ther ; 14(1): 76-81, 2021 Mar.
Article em En | MEDLINE | ID: mdl-30611712
Non-Hodgkin lymphoma (NHL) of the lip is extremely rare. It is usually indolent and in early stages a local approach is often indicated. We present a case report of a patient with extranodal NHL of the lip treated with chemotherapy and low-dose radiation treatment (RT). The patient was affected by B-cell NHL of the marginal zone, Stage IAE. After a few months of observation with progressive disease, the patient was submitted to two cycles of chemotherapy with no response. Therefore, he was treated with very low-dose RT consisting of two fractions of 2 Gy. Complete response was observed and after 1-year follow-up, persistent complete response was recorded. In cases of localized disease, especially in patients with comorbidities of poor performance status (PS), low-dose RT can be an appropriate approach with excellent outcomes in terms of effectiveness and low risk of toxicity.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Labiais / Linfoma de Zona Marginal Tipo Células B Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Labiais / Linfoma de Zona Marginal Tipo Células B Idioma: En Ano de publicação: 2021 Tipo de documento: Article